Forum > MS - RESEARCH AND NEWS

Addressing the rising prices of DMTs for MS (JAMA Neurol.)

(1/1)

agate:

From JAMA Neurology (August 26, 2019)--"Addressing the rising prices of disease-modifying therapies for multiple sclerosis." The authors are dealing with self-administered disease-modifying MS drugs.

http://bit.ly/34UPyj5


And in the same issue of JAMA Neurology, "Trends in prices, market share, and spending on self-administered disease-modifying therapies for multiple sclerosis in Medicare Part D":


http://bit.ly/2KfvArz

agate:
The MS Society has objected to the high price of the new drug Vumerity--from Multiple Sclerosis News Today (November 14, 2019), "National MS Society Objects to $88,000 List Price of Vumerity":


http://bit.ly/2KGCypV

Navigation

[0] Message Index